Edgewell delivered modest revenue growth in Q1 fiscal 2026 but reported an operating loss as inflation, restructuring charges, and mix pressures weighed on margins despite solid performance in Sun and Skin Care.

Edgewell posted a net loss for Q4 2025 despite higher sales, due to lower gross margins and a $51M impairment charge related to the Feminine Care divestiture.

Edgewell Personal Care Company experienced a challenging third fiscal quarter in 2025, with net sales decreasing by 3.2% to $627.2 million and GAAP EPS at $0.62, while Adjusted EPS was $0.92. The decline was primarily attributed to very weak Sun Care seasons in North America and certain Latin American markets, along with negative impacts from tariffs and foreign exchange. Despite these headwinds, the company saw strong performance in its International business and improved market share in key North American brands due to targeted investments.

Edgewell Personal Care reported a decrease in net sales and GAAP EPS for the second fiscal quarter of 2025 compared to the prior year. Gross margin increased, but operating income and net earnings declined. The company is maintaining an investment stance, focusing on brand equity and supporting innovation, while also updating its full-year outlook.

Edgewell Personal Care reported Q1 FY25 net sales of $478.4 million, down 2.1% YoY. GAAP EPS fell to -$0.04 from $0.09, while Adjusted EPS decreased to $0.07 from $0.24. Gross profit margin declined slightly to 40.1%. Operating income was $20.3 million, down from $26.1 million last year. Net cash used for operating activities increased to $115.6 million.

Edgewell Personal Care announced its fourth quarter and fiscal year 2024 results, with net sales decreasing by 3.1% to $517.6 million. Despite the sales decrease, the company achieved slight organic net sales growth for the fiscal year and anticipates a return to low single-digit organic net sales growth in fiscal 2025.

Edgewell Personal Care reported a slight decrease in net sales but a significant increase in adjusted EPS for Q3 2024. The company benefited from robust gross margin accretion and strong performance in its Right-to-Win portfolio, particularly in Sun Care and Grooming. The company is updating its full year outlook, anticipating sales growth of about 1% and increasing projections for adjusted EPS and EBITDA.

Edgewell Personal Care announced its second quarter fiscal 2024 results, with net sales increasing by 0.2% to $599.4 million. The company reported a significant increase in gross margin and adjusted EBITDA, leading to a substantial rise in both GAAP and adjusted EPS. The company has updated its full-year outlook, expecting sales at the lower end of the previous range but raising its outlook for adjusted EPS and EBITDA.

Edgewell Personal Care reported a 4.2% increase in net sales, reaching $488.9 million, with organic net sales growing by 3.1%. The company's gross margin was a highlight, driven by productivity savings and improved revenue management. Edgewell is maintaining its full-year outlook, reflecting confidence in its strategic priorities and operational execution.

Edgewell Personal Care reported a decrease in fourth-quarter net sales by 0.5% to $534.1 million. Despite the sales dip, the company's adjusted EPS was $0.72. The company is initiating Fiscal 2024 outlook for growth in Organic Net Sales, Adjusted EPS and Adjusted EBITDA.

Edgewell Personal Care announced strong Q3 2023 results, with net sales increasing by 4.2% to $650.0 million and organic net sales increasing by 4.5%. GAAP EPS grew by 77% and Adjusted EPS grew by 14%. The company is on track to deliver organic net sales growth slightly above the mid-point, adjusted EPS at the high-end, and adjusted EBITDA slightly above the high-end of the previously provided ranges.

Edgewell Personal Care announced strong Q2 fiscal 2023 results, featuring a 9.3% increase in net sales and an 11.4% rise in organic net sales. The company's performance was driven by growth across all segments and major geographic regions, reflecting strong consumer demand. Edgewell increased its fiscal year 2023 outlook for organic net sales growth to the high end of the previously provided range.

Edgewell Personal Care announced its first fiscal quarter 2023 results, with net sales of $469.1 million, a 1.3% increase compared to the prior year period, and organic net sales increased by 3.0%. The company maintains its fiscal 2023 outlook for organic net sales and adjusted EPS and EBITDA.

Edgewell Personal Care announced its fourth quarter and fiscal year 2022 results, with net sales decreasing by 1.2% to $536.9 million. Organic net sales increased by 1.2% for the quarter. The company provided a fiscal 2023 outlook expecting growth in organic net sales, adjusted EPS and adjusted EBITDA on a constant currency basis.

Edgewell Personal Care announced strong Q3 fiscal 2022 results, with net sales increasing by 8.7% to $623.8 million and organic net sales growing by 9.0%. The company's adjusted EPS was $0.86, compared to $0.89 in the prior year period. They narrowed the range for adjusted EPS and EBITDA for fiscal year 2022.

Edgewell Personal Care announced its second quarter fiscal 2022 results, with net sales increasing by 5.5% and organic net sales increasing by 2.1%. GAAP EPS was $0.43, while adjusted EPS was $0.50. The company repurchased $51 million of its common stock and paid $8.2 million of dividends. The company is increasing organic net sales outlook to reflect continued strong demand and incremental pricing, while lowering adjusted EPS and adjusted EBITDA estimates to reflect increased inflationary pressure.

Edgewell Personal Care reported a 2.7% increase in net sales to $463.3 million and a 2.5% increase in organic net sales for the first quarter of fiscal year 2022. GAAP EPS was $0.20, while adjusted EPS was $0.42, which included a $0.04 negative impact from the Billie acquisition. The company reaffirmed its fiscal year 2022 outlook, adjusting for the Billie acquisition and currency impacts.

Edgewell Personal Care announced strong Q4 and fiscal year 2021 results, with net sales increasing by 11.1% in Q4 and 7.1% for the full year. Organic net sales increased by 8.4% for the quarter and 3.7% for the full year. The company completed Project Fuel, achieving ~$280 million in cumulative gross savings, and initiated fiscal 2022 outlook for growth in organic net sales, adjusted EPS, and adjusted EBITDA. Additionally, the company announced its intent to repurchase approximately $300 million in common shares over the next three fiscal years.

Edgewell Personal Care announced strong third quarter fiscal 2021 results, with net sales increasing by 18.6% and organic net sales up 12.5%. The company raised its previously provided adjusted EPS and adjusted EBITDA outlook for fiscal 2021.

Edgewell Personal Care reported a slight decrease in net sales, but experienced growth in the Wet Shave segment. The company is maintaining its financial outlook for fiscal year 2021, focusing on organic sales growth and strategic investments.

Edgewell Personal Care announced its first quarter fiscal 2021 results, with net sales of $451.1 million, a decrease of 0.6% compared to the prior year period. Organic net sales were flat. GAAP EPS was $0.32, while adjusted EPS was $0.43. The company ended the quarter with $281 million in cash and returned $9.2 million to shareholders through share repurchase.

Edgewell Personal Care announced its fourth quarter and fiscal year 2020 results, showing a decrease in net sales compared to the prior year, but highlighted improvements in organic net sales trends and gross margin. The company also provided its financial outlook for fiscal year 2021, initiating net sales, organic sales, and adjusted EBITDA growth outlook.

Edgewell Personal Care reported a 20.6% decrease in net sales to $483.9 million for the third quarter of fiscal 2020. GAAP EPS was $0.09, while adjusted EPS was $0.66. The company also announced an agreement to acquire CREMO for approximately $235 million.

Edgewell Personal Care announced its second fiscal quarter results, reporting a decrease in net sales by 4.3% to $523.0 million, but an increase of 2.4% in organic net sales. GAAP EPS was $0.36, while adjusted EPS was $0.92. The company withdrew its fiscal year 2020 financial outlook due to COVID-19 uncertainties.

Edgewell Personal Care reported net sales of $454.0 million, a decrease of 0.7% compared to the prior year period, with organic net sales consistent with the prior year. GAAP EPS was $0.41, compared to a loss of $0.01 in the prior year, and adjusted EPS was $0.55, compared to $0.37 in the prior year. The company completed the sale of its Infant and Pet Care business for $122.5 million and terminated its merger agreement with Harry's, Inc.